patients with cPRA or TGI ≥ 95% on the deceased donor kidney transplant waiting list research hub

A Proof of Concept Study Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Dual Targeting Of Peripheral And Central Humoral Alloimmune Memory With Anti-CD38 (Daratumumab) And Costimulation Blockade With CTLA4-Ig (Belatacept) In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

This study is looking at a new treatment for people needing a kidney transplant who have a strong immune response to many donors. It tests two medicines to see if they can help these patients receive a kidney more easily and safely.